$0.7718
-0.0524-6.36%
Last update: Nov 12, 2:50 PM
iBio Inc
IBIONASDAQ
iBio fell 34.1% from $1.25 to $0.82, behind the S&P 500's +11.2%. Its worst day was Mar 26 (−20.2%), and its low came Oct 26 at $0.71.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.11 missed the $-0.07 estimate on $100,000.00 revenue (est. $55,000.00).
−8.0% · S&P 500 −1.7%
iBio shares rose 39.2%, while the S&P 500 fell 0.3%.
Story events cover the past 12 months · Times ET
+39.2%, the year's best day, on 114M shares, the year's heaviest volume · S&P 500 −0.3%
EPS of $-0.09 missed the $-0.07 estimate on $0.00 revenue (est. $59,998.00).
−2.6% · S&P 500 0.0%
iBio closed at its highest level of the year, 145.6% above where the year started.
+7.0% · S&P 500 −0.6%
iBio shares fell 20.2%, while the S&P 500 fell 1.8%.
−20.2%, the year's worst day · S&P 500 −1.8%
EPS of $-0.07 missed the $-0.06 estimate on $0.00 revenue (est. $36,000.00).
−3.7% · S&P 500 +0.6%
EPS of $-0.06 beat the $-0.06 estimate on $0.00 revenue (est. $66,670.00).
−2.9% · S&P 500 −0.2%
iBio closed at its lowest level of the year, 43.4% below where the year started.
−1.5% · S&P 500 +0.7%
EPS of $-0.05 beat the $-0.07 estimate on $1.1M revenue (est. $16,670.00).
+5.7% · S&P 500 +1.3%
Where it ended: a close of $0.82 on Nov 11, 2026. Up next: Q2 2027 earnings on Feb 9, 2027 (EPS est. $-0.08).
Nothing in the past 12 months.
All IBIO dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IBIO and SPY from Benzinga historical bars. Not investment advice.
